Life Technologies Makes Automated Cell Imaging Accessible to All Labs

    Life Technologies Makes Automated Cell Imaging Accessible to All Labs

The EVOS® FL Auto Imaging System and on-stage incubator enables ease-of-use
and broad applications for fluorescence microscopy on single integrated

PR Newswire

CARLSBAD, Calif., July 15, 2013

CARLSBAD, Calif., July 15, 2013 /PRNewswire/ --Life Technologies Corporation
(NASDAQ: LIFE) today announces the launch of EVOS® FL Auto Imaging System with
an on-stage incubator designed to enable time-lapse, high-resolution live cell
imaging in a fully automated system that is priced to make high-resolution,
fluorescence microscopy simple and accessible for any lab.

Priced significantly less than other instruments on the market, the EVOS® FL
Auto Imaging System is a fully integrated platform capable of meeting a broad
range of research applications, from image tiling and multi-position well
scanning to automated cell counting. When combined with the incubator system,
which controls environmental temperature, oxygen and humidity directly on the
instrument stage, the cell imaging system enables longer live cell culture
monitoring sessions and time-lapse imaging.

"When I was a post doc, people spent more than a year getting a confocal
system with live cell chamber to work," said Karen Schindler, assistant
professor, Rutgers University, Department of Genetics."When I started my lab,
I looked for a system that was easy to use, had a small footprint and could
support our finicky cells. I was skeptical to have the demo on the EVOS system
done in two days. It was so easy. I realized even students with limited
knowledge could use it."

Simple and Economical to Use

At the heart of the system is its intuitive and automated workflow, which
underscores Life Technologies' commitment to developing innovative platforms
that benefit its customers and support their cell analysis research. The EVOS®
FL Auto Imaging System is designed for novice and experienced users alike with
minimal upfront training requirements. The system's proprietary EVOS® LED
light cubes also reduce operational costs, eliminating the need to replace
burned-out arc lamps.

"The EVOS FL Auto Imaging System provides an excellent value giving
researchers a full-featured, multichannel fluorescent instrument that does not
require an in-lab expert to operate," said Siddhartha Kadia, Ph.D., President,
Life Sciences at Life Technologies. "It represents our drive to provide the
industry with innovative microscopy platforms that reduce complexity and allow
our customers to spend less time on instrument operation and more time
analyzing results."

The EVOS® FL Auto Imaging System is for research use only, not intended for
diagnostic purposes.

About Life Technologies

Life Technologies Corporation(NASDAQ:LIFE) is a global biotechnology company
that is committed to providing the most innovative products and services to
leading customers in the fields of scientific research, genetic analysis and
applied sciences. With a presence in more than 180 countries, the company's
portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents
and licenses that span the entire biological spectrum -- scientific
exploration, molecular diagnostics, 21^stcentury forensics, regenerative
medicine and agricultural research. Life Technologies has approximately 10,000
employees and had sales of $3.8 billion in 2012.

Life Technologies' Safe Harbor Statement

This press release includes forward-looking statements about our anticipated
results that involve risks and uncertainties. Some of the information
contained in this press release, including, but not limited to, statements as
to industry trends and Life Technologies' plans, objectives, expectations and
strategy for its business, contains forward-looking statements that are
subject to risks and uncertainties that could cause actual results or events
to differ materially from those expressed or implied by such forward-looking
statements. Any statements that are not statements of historical fact are
forward-looking statements. When used, the words "believe," "plan," "intend,"
"anticipate," "target," "estimate," "expect" and the like, and/or future tense
or conditional constructions ("will," "may," "could," "should," etc.), or
similar expressions, identify certain of these forward-looking statements.
Important factors which could cause actual results to differ materially from
those in the forward-looking statements are detailed in filings made byLife
Technologies with the Securities and Exchange Commission.Life Technologies
undertakes no obligation to update or revise any such forward-looking
statements to reflect subsequent events or circumstances.


Life Technologies Contact
Mauricio Minotta

SOURCE Life Technologies Corporation

Press spacebar to pause and continue. Press esc to stop.